SYSTEMATIC REVIEW OF POLY (ADP-RIBOSE) POLYMERASE INHIBITORS FOR TREATMENT OF OVARIAN CANCER

被引：1
|
作者：
Menges, B. [1 ]
Deitelzweig, C. [1 ]
Lin, J. [1 ]
Lingohr-Smith, M. [1 ]
Lin, G. [1 ]
机构：
[1] Novosys Hlth, Green Brook, NJ USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.107
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN29
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [1] Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer (Review)
    Wiggans, Alison J.
    Cass, Gemma K. S.
    Bryant, Andrew
    Lawrie, Theresa A.
    Morrison, Jo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (02):
  • [2] Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer
    Wiggans, Alison J.
    Cass, Gemma K. S.
    Bryant, Andrew
    Lawrie, Theresa A.
    Morrison, Jo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (05):
  • [3] Poly (ADP-ribose) Polymerase Inhibitors in Cancer Treatment
    Mason, Kathryn A.
    Raju, Uma
    Buchholz, Thomas A.
    Wang, Li
    Milas, Zvonimir L.
    Milas, Luka
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (01): : 90 - 100
  • [4] Poly(ADP-ribose) polymerase (PARP) inhibitors and ovarian cancer
    Liu, Chia-Hao
    Chang, Yi
    Wang, Peng-Hui
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2017, 56 (05): : 713 - 714
  • [5] Poly (ADP-ribose) polymerase inhibitors in the management of ovarian cancer
    Markman, Maurie
    WOMENS HEALTH, 2018, 14 : 1 - 6
  • [6] Cost-Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Cancer Treatment: A Systematic Review
    Chan, Vivien Kin Yi
    Yang, Runqing
    Wong, Ian Chi Kei
    Li, Xue
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] Real-world evidence of poly ADP-ribose polymerase inhibitors in the treatment of ovarian cancer: A systematic literature review
    Borrelli, Eric P.
    McGladrigan, Conor G.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (08) : 1977 - 1986
  • [8] Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
    Boussios, Stergios
    Abson, Charlotte
    Moschetta, Michele
    Rassy, Elie
    Karathanasi, Afroditi
    Bhat, Tahir
    Ghumman, Faisal
    Sheriff, Matin
    Pavlidis, Nicholas
    DRUGS IN R&D, 2020, 20 (02) : 55 - 73
  • [9] Update on poly(ADP-ribose) polymerase inhibitors resistance in ovarian cancer
    Dong, Ruihong
    Ding, Ting
    Li, Zhengyu
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [10] Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
    Stergios Boussios
    Charlotte Abson
    Michele Moschetta
    Elie Rassy
    Afroditi Karathanasi
    Tahir Bhat
    Faisal Ghumman
    Matin Sheriff
    Nicholas Pavlidis
    Drugs in R&D, 2020, 20 : 55 - 73
12345